Suchergebnisse - "Chau, Ian"

PubPharm (22)

1

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer : 2-year update of the randomized phase 3 KEYNOTE-061 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2022

von Fuchs, C. | Özgüroğlu, M. | Bang, Y. | +17

2

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial

enthalten in: Gastric cancer | 2021

von Fuchs, C. | Özgüroğlu, M. | Bang, Y. | +17

3

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial

enthalten in: Gastric cancer | 2021

von Fuchs, C. | Özgüroğlu, M. | Bang, Y. | +17

4

Neoadjuvant and adjuvant multimodality therapies in resectable esophagogastric adenocarcinoma

enthalten in: Expert opinion on pharmacotherapy | 2021

von Lau, D. | Athauda, A. | Chau, I.

5

A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas

enthalten in: Advances in therapy | 2021

von Shankaran, V. | Xiao, H. | Bertwistle, D. | +4

6

A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas

enthalten in: Advances in therapy | 2020

von Shankaran, V. | Xiao, H. | Bertwistle, D. | +4

7

A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas

enthalten in: Advances in therapy | 2020

von Shankaran, V. | Xiao, H. | Bertwistle, D. | +4

8

A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas

enthalten in: Advances in therapy | 2020

von Shankaran, V. | Xiao, H. | Bertwistle, D. | +4

9

Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer : A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Athauda, A. | Nankivell, M. | Langley, R. | +6

10

Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer

enthalten in: BMC gastroenterology | 2020

von Gómez-Ulloa, D. | Amonkar, M. | Kothari, S. | +5